Cargando…
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer
Oncolytic viruses (OVs) are promising therapeutics for tumors with a poor prognosis. An OV based on herpes simplex virus type 1 (oHSV-1), talimogene laherparepvec (T-VEC), has been recently approved by the Food and Drug Administration (FDA) and by the European Medicines Agency (EMA) for the treatmen...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253092/ https://www.ncbi.nlm.nih.gov/pubmed/37298206 http://dx.doi.org/10.3390/ijms24119255 |
_version_ | 1785056325002067968 |
---|---|
author | Reale, Alberto Krutzke, Lea Cadamuro, Massimiliano Vitiello, Adriana von Einem, Jens Kochanek, Stefan Palù, Giorgio Parolin, Cristina Calistri, Arianna |
author_facet | Reale, Alberto Krutzke, Lea Cadamuro, Massimiliano Vitiello, Adriana von Einem, Jens Kochanek, Stefan Palù, Giorgio Parolin, Cristina Calistri, Arianna |
author_sort | Reale, Alberto |
collection | PubMed |
description | Oncolytic viruses (OVs) are promising therapeutics for tumors with a poor prognosis. An OV based on herpes simplex virus type 1 (oHSV-1), talimogene laherparepvec (T-VEC), has been recently approved by the Food and Drug Administration (FDA) and by the European Medicines Agency (EMA) for the treatment of unresectable melanoma. T-VEC, like most OVs, is administered via intratumoral injection, underlining the unresolved problem of the systemic delivery of the oncolytic agent for the treatment of metastases and deep-seated tumors. To address this drawback, cells with a tropism for tumors can be loaded ex vivo with OVs and used as carriers for systemic oncolytic virotherapy. Here, we evaluated human monocytes as carrier cells for a prototype oHSV-1 with a similar genetic backbone as T-VEC. Many tumors specifically recruit monocytes from the bloodstream, and autologous monocytes can be obtained from peripheral blood. We demonstrate here that oHSV-1-loaded primary human monocytes migrated in vitro towards epithelial cancer cells of different origin. Moreover, human monocytic leukemia cells selectively delivered oHSV-1 to human head-and-neck xenograft tumors grown on the chorioallantoic membrane (CAM) of fertilized chicken eggs after intravascular injection. Thus, our work shows that monocytes are promising carriers for the delivery of oHSV-1s in vivo, deserving further investigation in animal models. |
format | Online Article Text |
id | pubmed-10253092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102530922023-06-10 Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer Reale, Alberto Krutzke, Lea Cadamuro, Massimiliano Vitiello, Adriana von Einem, Jens Kochanek, Stefan Palù, Giorgio Parolin, Cristina Calistri, Arianna Int J Mol Sci Article Oncolytic viruses (OVs) are promising therapeutics for tumors with a poor prognosis. An OV based on herpes simplex virus type 1 (oHSV-1), talimogene laherparepvec (T-VEC), has been recently approved by the Food and Drug Administration (FDA) and by the European Medicines Agency (EMA) for the treatment of unresectable melanoma. T-VEC, like most OVs, is administered via intratumoral injection, underlining the unresolved problem of the systemic delivery of the oncolytic agent for the treatment of metastases and deep-seated tumors. To address this drawback, cells with a tropism for tumors can be loaded ex vivo with OVs and used as carriers for systemic oncolytic virotherapy. Here, we evaluated human monocytes as carrier cells for a prototype oHSV-1 with a similar genetic backbone as T-VEC. Many tumors specifically recruit monocytes from the bloodstream, and autologous monocytes can be obtained from peripheral blood. We demonstrate here that oHSV-1-loaded primary human monocytes migrated in vitro towards epithelial cancer cells of different origin. Moreover, human monocytic leukemia cells selectively delivered oHSV-1 to human head-and-neck xenograft tumors grown on the chorioallantoic membrane (CAM) of fertilized chicken eggs after intravascular injection. Thus, our work shows that monocytes are promising carriers for the delivery of oHSV-1s in vivo, deserving further investigation in animal models. MDPI 2023-05-25 /pmc/articles/PMC10253092/ /pubmed/37298206 http://dx.doi.org/10.3390/ijms24119255 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Reale, Alberto Krutzke, Lea Cadamuro, Massimiliano Vitiello, Adriana von Einem, Jens Kochanek, Stefan Palù, Giorgio Parolin, Cristina Calistri, Arianna Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer |
title | Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer |
title_full | Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer |
title_fullStr | Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer |
title_full_unstemmed | Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer |
title_short | Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer |
title_sort | human monocytes are suitable carriers for the delivery of oncolytic herpes simplex virus type 1 in vitro and in a chicken embryo chorioallantoic membrane model of cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253092/ https://www.ncbi.nlm.nih.gov/pubmed/37298206 http://dx.doi.org/10.3390/ijms24119255 |
work_keys_str_mv | AT realealberto humanmonocytesaresuitablecarriersforthedeliveryofoncolyticherpessimplexvirustype1invitroandinachickenembryochorioallantoicmembranemodelofcancer AT krutzkelea humanmonocytesaresuitablecarriersforthedeliveryofoncolyticherpessimplexvirustype1invitroandinachickenembryochorioallantoicmembranemodelofcancer AT cadamuromassimiliano humanmonocytesaresuitablecarriersforthedeliveryofoncolyticherpessimplexvirustype1invitroandinachickenembryochorioallantoicmembranemodelofcancer AT vitielloadriana humanmonocytesaresuitablecarriersforthedeliveryofoncolyticherpessimplexvirustype1invitroandinachickenembryochorioallantoicmembranemodelofcancer AT voneinemjens humanmonocytesaresuitablecarriersforthedeliveryofoncolyticherpessimplexvirustype1invitroandinachickenembryochorioallantoicmembranemodelofcancer AT kochanekstefan humanmonocytesaresuitablecarriersforthedeliveryofoncolyticherpessimplexvirustype1invitroandinachickenembryochorioallantoicmembranemodelofcancer AT palugiorgio humanmonocytesaresuitablecarriersforthedeliveryofoncolyticherpessimplexvirustype1invitroandinachickenembryochorioallantoicmembranemodelofcancer AT parolincristina humanmonocytesaresuitablecarriersforthedeliveryofoncolyticherpessimplexvirustype1invitroandinachickenembryochorioallantoicmembranemodelofcancer AT calistriarianna humanmonocytesaresuitablecarriersforthedeliveryofoncolyticherpessimplexvirustype1invitroandinachickenembryochorioallantoicmembranemodelofcancer |